Interstitial lung disease increases susceptibility to and severity of COVID-19
There are limited data regarding the relationship between interstitial lung disease (ILD) and the natural course of coronavirus disease 2019 (COVID-19). In this study, we investigate whether patients with ILD are more susceptible to COVID-19 than those without ILD and evaluate the impact of ILD on d...
Saved in:
Published in | The European respiratory journal Vol. 58; no. 6; p. 2004125 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
European Respiratory Society
22.04.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0903-1936 1399-3003 1399-3003 |
DOI | 10.1183/13993003.04125-2020 |
Cover
Summary: | There are limited data regarding the relationship between interstitial lung disease (ILD) and the natural course of coronavirus disease 2019 (COVID-19). In this study, we investigate whether patients with ILD are more susceptible to COVID-19 than those without ILD and evaluate the impact of ILD on disease severity in patients with COVID-19.
A nationwide cohort of patients with COVID-19 (n=8070) and a 1:15 age-, sex-, and residence-matched cohort (n=121 050) were constructed between January 1, 2020 and May 30, 2020 in Korea. We performed a nested case-control study to compare the proportions of patients with ILD between the COVID-19 cohort and the matched cohort. Using the COVID-19 cohort, we also evaluated the risk of severe COVID-19 in patients with ILD
those without ILD.
The proportion of patients with ILD was significantly higher in the COVID-19 cohort than in the matched cohort (0.8%
0.4%, p<0.001). The odds ratio [OR] of having ILD was significantly higher in the COVID-19 cohort than in the matched cohort (adjusted OR=2.02, 95% confidence interval [CI]=1.54-2.61). Among patients in the COVID-19 cohort, patients with ILD were more likely to have severe COVID-19 than patients without ILD (49.3%
13.1%), including mortality (13.4%
2.8%) (all p<0.01). The risk of severe COVID-19 was significantly higher in patients with ILD than in those without ILD (adjusted OR=2.32, 95% CI=1.24-4.01).
The risks of COVID-19 and severe presentation were significantly higher in patients with ILD than in those without ILD. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0903-1936 1399-3003 1399-3003 |
DOI: | 10.1183/13993003.04125-2020 |